Personalized treatment approach for pancreatic cancer patients
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial studies how doctors choose individualized cancer treatment for people with pancreatic cancer. It may help them learn which treatment choices work best for different patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have confirmed pancreatic cancer (diagnosed on tissue/pathology testing)
- You can understand the study information in writing and agree to sign consent
- The main cancer you were diagnosed with must be pancreatic cancer
- The trial is not for people under 18
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses advanced genetic testing on your tumor sample and lab-grown tumor 'organoids' to help pick treatments that may work better for your metastatic pancreatic cancer. The goal is to find a more personalized treatment plan for you.
This trial tests if personalized medicines, chosen based on the genetic profile of your tumor, can help prevent pancreatic cancer from coming back after surgery. It is for people who have had their pancreatic tumor removed but have features that suggest a higher chance of recurrence.
This early-phase study tests whether a personalized cancer treatment plan based on your tumor’s test results can help people with aggressive cancers that are hard to treat. It may be an option if standard treatments didn’t work, aren’t possible for you, or you have few treatment choices.
This trial tests treatments that are chosen specifically for you based on the genetic makeup of your tumor. The goal is to find a targeted therapy that may work better for your advanced pancreatic cancer after standard chemotherapy has stopped being effective.
This trial is testing a new way to treat pancreatic cancer that has spread to nearby tissues but not to distant organs. It uses a tailored plan that may include chemotherapy and possibly surgery. The goal is to see if this personalized approach helps people live longer and better.
This study uses a personalized blood test to look for tiny pieces of tumor DNA in people with pancreatic cancer. It helps doctors understand how the cancer changes during treatment.
Hear when a new Pancreatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.